Is a complete LON/0EVI research report available?

No complete published report is available for lon/0EVI (LON/0EVI) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

LON/0EVI (LON/0EVI)

London Stock Exchange: LON/0EVI · EUR

€1.59

-0.01 (-0.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first LON/0EVI analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	127M
Revenue (ttm)	7.9M
Net income (ttm)	-42.9M
EPS (ttm)	-€0.48
Volume	264
Beta	0.88

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 7.9M
Net income (ttm): -42.9M
EPS (ttm): -€0.48
Market cap: 127M

All LON/0EVI indicators

Market & fundamental data

Available fields

155

Groups with data

Currency

EUR

Showing 155 of 155 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	UK
Employees	164
Enterprise value	EUR 116.9M
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-07-30
Market cap	EUR 127M
Price	EUR 1.59
Price currency	EUR
Rev Per Employee	47,900.72x
Sic	2836
Symbol	lon/0EVI
Website	https://www.innate-pharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-33.79%
EV/Sales	15.16x
FCF yield	-36.34%
P/B ratio	-6.71x
P/S ratio	16.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -30.2M
Net Income	EUR -42.9M
Pretax Margin	-546.11%
Profit Per Employee	EUR -261,590
ROA	-38.85
Roa5y	-16.08
ROCE	-207.2
ROIC	-207.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-17.1%
Cagr1y	-9.02%
Cagr3y	-17.04%
Cagr5y	-9.24%
Revenue Growth	-55.25x
Revenue Growth Q	-46.7x
Revenue Growth3 Y	-46.15x
Revenue Growth5 Y	-33.05x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.1
Assets	EUR 54.7M
Cash	EUR 29.9M
Current Assets	EUR 40.1M
Current Liabilities	EUR 31.4M
Debt	EUR 19.7M
Debt FCF	EUR -0.43
Equity	EUR -18.9M
Interest Coverage	-122.7
Liabilities	EUR 73.6M
Long Term Assets	EUR 14.6M
Long Term Liabilities	EUR 42.2M
Net Cash	EUR 10.2M
Net Cash By Market Cap	EUR 8.06
Net Cash Growth	-76.42%
Tangible Book Value	EUR -18.9M
Tangible Book Value Per Share	EUR -0.2
WACC	8.06

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.27
Net Working Capital	EUR -13.5M
Quick ratio	1.14
Working Capital	EUR 8.8M
Working Capital Turnover	EUR 0.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-84.67%
1Y total return	-9.01%
200-day SMA	1.51
3Y total return	-42.91%
50-day SMA	1.6
50-day SMA vs 200-day SMA	50over200
5Y total return	-38.4%
All Time High	17.23
All Time High Change	-90.5%
All Time High Date	2015-04-27
All Time Low	1.04
All Time Low Change	57.31%
All Time Low Date	2026-03-23
ATR	0.05
Beta	0.88
Ch YTD	0.74
High	1.61
High52	2.2
High52 Date	2026-05-15
High52ch	-27.59%
Low	1.59
Low52	1.04
Low52 Date	2026-03-31
Low52ch	53.17%
Ma50ch	2.51%
Price vs 200-day SMA	8.42%
RSI	52.66
RSI Monthly	45.96
RSI Weekly	53.46
Sharpe ratio	-0.03x
Sortino ratio	0.06
Total Return	-10.54%
Tr YTD	0.74
Tr1m	3.81%
Tr1w	5.01%
Tr3m	41.03%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -47.1M
Operating margin	-599.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	70,666,485%
Net Borrowing	-7,644,005.6
Shares Insiders	0.74%
Shares Institutions	1.48%
Shares Qo Q	6.11%
Shares Yo Y	10.54%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -48.4M
Adjusted OCF	-48,261,413
Average Volume	2,402.4x
Bv Per Share	-0.2
CAPEX	EUR -122,132
Ch10y	-84.67
Ch1m	3.81
Ch1w	5.01
Ch1y	-9.01
Ch3m	41.03
Ch3y	-42.92
Ch5y	-38.4
Ch6m	9.8
Change	-0.81%
Change From Open	-2.27
Close	1.61
Days Gap	1.49
Depreciation Amortization	600,471.8
Dollar Volume	420.6
Earnings Date	2026-09-17
EBIT	EUR -47.1M
EBITDA	EUR -46.5M
EPS	EUR -0.48
F Score	1
FCF	EUR -46.1M
FCF EV Yield	-39.47x
Financing CF	5,295,304
Fiscal Year End	December
Founded	1,999
Investing CF	6,358,726
Is Primary Listing	0
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Ma150	1.45
Ma150ch	12.67%
Ma20	1.6
Ma20ch	2.44%
Net CF	-33,415,372
Next Earnings Date	2026-09-17
Open	1.63
Position In Range	0
Ppne	3,736,650
Price Date	2026-07-29
Relative Volume	0.11x
Revenue	7,855,718x
SBC By Revenue	28.51x
Share Based Comp	2,239,381
Tr6m	9.8%
Volume	264
Z Score	-11.09

LON/0EVI (LON/0EVI)

Coverage state: Market snapshot only — no published research

Generate the first LON/0EVI analysis

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0EVI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0EVI indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on LON/0EVI

Frequently asked questions